Category: Health
Achilles Therapeutics, a biopharmaceutical company committed to the development of personalized cancer immunotherapies, has reportedly attained the approval of its Clinical Trial Application to perform a Phase I/II study on patients with melanoma by the UK Medicines and Healthcare products Regulatory Agency. As per trusted …
The terms of the agreement state that Glenmark will be accountable for developing and supplying Ryaltris across China. Globally renowned pharmaceutical major Glenmark Pharmaceuticals has reportedly announced that its Swiss subsidiary has signed an exclusive licensing pact with Grandpharma (China) Co. Credible sources claim that …
British pharmaceutical firm GlaxoSmithKline plc has recently agreed to pay up to €3.7 billion (US$4.22 billion) to Merck KGaA for obtaining rights to an innovative immunotherapy. Apparently, this move has come from GlaxoSmithKline (GSK) in a bid to strengthen its cancer drug development pipeline. The …
The collaboration will effectively help optimize the delivery of Beta-C and several other active ingredients into patient’s skin and local tissues. Canada’s dermatology firm, Crescita Therapeutics Inc. and leading cannabinoid-derived drug provider, Tetra Bio-Pharma’s subsidiary, Tetra Natural Health (NHP) have recently announced an arrangement to …
Magnolia Medical Technologies, Inc. has recently announced a Series C financing round of $20 million for scaling the infrastructure as well as market initiatives of the company. Apparently, these efforts from the company signify an attempt to meet the fast growing demand for its Steripath® …
Over a larger debate on drug prices in the U.S., pharmacy-benefit managers like the CVS have lately attracted criticism from regulators. Reports suggest that due to a dispute between Walmart Inc. and CVS Health Corp., Walmart pharmacies would no longer be a part of the …
Vanderbilt University Medical Center (VUMC) has recently announced that it has entered into a five-year partnership with GE Healthcare for enabling more precise and safer cancer immunotherapies. Apparently, various diagnostic tools would be developed for predicting the immunotherapy treatment’s efficacy as well as its adverse …
The deal will grant Gilead rights over HOOKIPA’s immunization technologies for developing immunotherapies against HIV and HBV. HOOKIPA Pharma Inc., a clinical-stage company developing novel immunotherapies targeting infectious diseases and cancers, has recently acquired its first research milestone through a collaboration and license agreement with …